HEMGENIX Trademark
Serial Number: 97037223 • Registration: 7045999
HEMGENIX is a trademark filed by
CSL BEHRING L.L.C.
on September 21, 2021. The trademark is classified under Class 5 (Pharmaceuticals).
The application is currently registered and active.
Trademark Classes
Owner Contact Info
Legal Representation
Trademark Details
Filing Date
September 21, 2021
Registration Date
May 9, 2023
Published for Opposition
February 21, 2023
Goods & Services
Pharmaceutical preparations for use in gene therapy and cell therapy for the treatment of hemophilia
Filing History
REGISTERED-PRINCIPAL REGISTER
May 9, 2023 R.PR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 9, 2023 NRCC
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 21, 2023 NPUB
PUBLISHED FOR OPPOSITION
Feb 21, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 1, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 18, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 6, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 6, 2023 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Jan 6, 2023 ERSI
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 30, 2022 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 30, 2022 GNSL
SUSPENSION LETTER WRITTEN
Dec 30, 2022 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 27, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 27, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 27, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 27, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 27, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 22, 2022 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Oct 26, 2021 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 24, 2021 NWOS
NEW APPLICATION ENTERED
Sep 24, 2021 NWAP